Free weekly newsletter
Get the free weekly contract digest
The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Oncocyte Corporation Announces $10.2 Million Private Placement of Securities
Oct 02, 2024•over 1 year ago
Contract Type
partnership
IrvineBiotechnologyHealth CareGeneticsHealth DiagnosticsDescription
Oncocyte Corporation has entered into a securities purchase agreement with new and existing investors, including Bio-Rad Laboratories, Inc. The company expects to receive approximately $10.2 million from the private placement, which will be used for working capital and general corporate purposes. This partnership demonstrates strong support from both current and new shareholders, including their corporate partner, Bio-Rad Laboratories, Inc.
Related People
Suggested for you
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months